Metformin 500 mg

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC, Boehringer Ingelheim, Taipei Medical University WanFang Hospital, Mst.Sumyara Khatun

Conditions

HealthyMetabolic SyndromePCOSType 2 Diabetes Mellitus

Phase 1

Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets

CompletedNCT02028767

Boehringer IngelheimHealthy

Start: 2014-01-31End: 2014-02-28Updated: 2015-07-24

Phase 3

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

CompletedNCT01076088

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2010-11-15End: 2012-12-24Updated: 2017-05-23

Phase 4

Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities

CompletedNCT02751307

Taipei Medical University WanFang HospitalMetabolic Syndrome

Start: 2013-05-31End: 2015-01-31Updated: 2016-04-28

Unknown Phase

Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH

CompletedNCT07513480

Mst.Sumyara KhatunPCOS

Start: 2024-08-12End: 2026-02-20Updated: 2026-04-07

Related Papers

Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

PLoS ONE2016-12-1418 citations